Recent work has implicated inflammatory processes in the pathophysiology of a variety of neurodegenerative diseases such as Alzheimer's disease, stroke and multiple sclerosis. In this book leading experts in the field discuss molecular, in vivo and clinical aspects of neuroinflammation. It is hoped, with the wealth of research being conductied in this area, that novel therapeutic targets will be identified which will allow successful therapeutic intervention in a variety of neurodegenerative diseases.
Recent work has implicated inflammatory processes in the pathophysiology of a variety of neurodegenerative diseases such as Alzheimer's disease, stroke and multiple sclerosis. In this book leading experts in the field discuss molecular, in vivo and clinical aspects of neuroinflammation. It is hoped, with the wealth of research being conductied in this area, that novel therapeutic targets will be identified which will allow successful therapeutic intervention in a variety of neurodegenerative diseases.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
Produktdetails
Ernst Schering Foundation Symposium Proceedings 39
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Helmut Kettenmann, Max-Delbrück Center for Molecular Medicine, Berlin, Germany / Gerardine A. Burton, Schering AG, Berlin, Germany / Ursula Moenning, Schering AG, Berlin, Germany
Inhaltsangabe
1 Cellular Components of Neuroinflammation - An Introduction.- 2 Microglia and the Response to Brain Injury.- 3 Elucidating Molecular Mechanisms of Alzheimer's Disease in Microglial Cultures.- 4 Neuronal SLC (CCL21) Expression: Implications for Neuron-Microglial Signaling System.- 5 Cytokine-Mediated Inflammation and Other Actions in the Central Nervous System.- 6 BSE, Scrapie, and vCJD: Infectious Neurodegenerative Diseases.- 7 Activated Microglia in Alzheimer's Disease and Stroke.- 8 Inflammation in Stroke - A Potential Target for Neuroprotection?.- 9 Neuroinflammation in Alzheimer's Disease: Potential Targets for Disease-Modifying Drugs.- 10 The Concept of In Vivo Imaging of Neuroinflammation with [11C](R)-PK11195 PET.- 11 Chemokine Receptors on Mononuclear Phagocytes in the Central Nervous System of Patients with Multiple Sclerosis.- 12 The Role of Apoptosis in Neuroinflammation.- Previous Volumes Published in This Series.
1 Cellular Components of Neuroinflammation - An Introduction.- 2 Microglia and the Response to Brain Injury.- 3 Elucidating Molecular Mechanisms of Alzheimer's Disease in Microglial Cultures.- 4 Neuronal SLC (CCL21) Expression: Implications for Neuron-Microglial Signaling System.- 5 Cytokine-Mediated Inflammation and Other Actions in the Central Nervous System.- 6 BSE, Scrapie, and vCJD: Infectious Neurodegenerative Diseases.- 7 Activated Microglia in Alzheimer's Disease and Stroke.- 8 Inflammation in Stroke - A Potential Target for Neuroprotection?.- 9 Neuroinflammation in Alzheimer's Disease: Potential Targets for Disease-Modifying Drugs.- 10 The Concept of In Vivo Imaging of Neuroinflammation with [11C](R)-PK11195 PET.- 11 Chemokine Receptors on Mononuclear Phagocytes in the Central Nervous System of Patients with Multiple Sclerosis.- 12 The Role of Apoptosis in Neuroinflammation.- Previous Volumes Published in This Series.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826